A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer ...
Roivant Sciences has seen only a marginal shift in its modeled fair value, from US$35.67 to US$35.71, keeping the headline price target effectively stable. That small move reflects a tug of war in ...
Key Points Interested in Roivant Sciences Ltd.? Here are five stocks we like better. IMVT-1402 posted encouraging preliminary results in difficult-to-treat rheumatoid arthritis, with about 73% of ...
Key market opportunities for YUTIQ stem from the growing need for long-term management of non-infectious posterior uveitis, its advantages in sustained drug delivery, and its expanding ...
Medical specialists at public hospitals are disputing health minister Esperance Luvindao's claims that medicine stock levels have improved.The doctors, who have spoken to The Namibian on condition of ...
A clinical-stage Israeli biotech advancing steroid-free therapies for ocular diseases, with a lead program in Phase III ...
Key Points Interested in Immunovant, Inc.? Here are five stocks we like better. IMVT-1402 showed encouraging open-label results in difficult-to-treat rheumatoid arthritis, with about 73% ACR20 ...
Medicover Hospitals, Hitec City, has launched a state-of-the-art Advanced Eye Centre offering specialised cataract, retina, corneal and neuro-ophthalmology services. Inaugurated by Amala Akkineni, the ...
IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA) ...
Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...